Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A bacterial biofilm is a complex, structured community of microorganisms, primarily bacteria, that are embedded within a self-produced matrix of extracellular polymeric substances (EPS). This matrix provides structural integrity and protection, making biofilms highly resistant to antibiotics and host immune responses. Targeting biofilms aims to disrupt their formation, degrade the matrix, or enhance antibiotic penetration to eradicate persistent infections.
Disrupting biofilm formation, degrading EPS matrix, inhibiting quorum sensing, increasing antibiotic penetration, promoting biofilm dispersal
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Biofilm (N/A).